[EN] NAPHT- 2 -YLACETIC ACID DERIVATIVES TO TREAT AIDS<br/>[FR] DÉRIVÉS D'ACIDE NAPHT-2-YLACÉTIQUE DANS LE TRAITEMENT DU SIDA
申请人:GILEAD SCIENCES INC
公开号:WO2012003497A1
公开(公告)日:2012-01-05
The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds of formula (I).
A concise synthesis of 1‐naphthols via cyclization of o‐iodoacetophenones and methyl ketones has been realized under very mild conditions. The cyclization process is initiated by a rare copper‐catalyzed arylation of simple methyl ketones with ortho‐iodoacetophenones.
Herein, we report a safe and economical multigramsynthesis of 6-fluoromenadione, an intermediate in the synthesis of novel biologically active agents. The key to this six-step sequence process involves the condensation of the readily available starting 4′-fluoropropiophenone and glyoxylic acid, a bromination–elimination sequence from 7-fluoro-3-methyltetral-1-one allowing aromatization of the naphthol
NAPHTHALENE ACETIC ACID DERIVATIVES AGAINST HIV INFECTION
申请人:Gilead Sciences, Inc.
公开号:US20150111891A1
公开(公告)日:2015-04-23
The invention provides compounds and salts thereof as d herein. The invention also provides pharmaceutical compositions comprising a compound disclosed herein, processes for preparing compounds disclosed herein, intermediates useful for preparing compounds disclosed herein and therapeutic methods for treating an HIV infection, treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds disclosed herein.
The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds of formula (I).